{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T07:18:27Z","timestamp":1788679107702,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000341","name":"Arthritis Research UK","doi-asserted-by":"publisher","award":["#20380"],"award-info":[{"award-number":["#20380"]}],"id":[{"id":"10.13039\/501100000341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12969-017-0161-5","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T00:16:21Z","timestamp":1492560981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities"],"prefix":"10.1186","volume":"15","author":[{"given":"Timothy","family":"Beukelman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke","family":"Anink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillemor","family":"Berntson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciaran","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine A.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Glerup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Horneff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianne","family":"Kearsley-Fleet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Klotsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Magnusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Minden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane E.","family":"Munro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Niewerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Nordal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolino","family":"Ruperto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jose","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Schanberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisette","family":"van Suijlekom-Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Wulffraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimme","family":"Hyrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,19]]},"reference":[{"key":"161_CR1","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390\u20132.","journal-title":"J Rheumatol"},{"key":"161_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jbspin.2013.09.003","volume":"81","author":"S Thierry","year":"2014","unstructured":"Thierry S, Fautrel B, Lemelle I, Guillemin F. Prevalence and incidence of juvenile idiopathic arthritis: a systematic review. Joint Bone Spine. 2014;81:112\u20137.","journal-title":"Joint Bone Spine"},{"key":"161_CR3","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.3899\/jrheum.131536","volume":"41","author":"J Guzman","year":"2014","unstructured":"Guzman J, Gomez-Ramirez O, Jurencak R, Shiff NJ, Berard RA, Duffy CM, et al. What matters most for patients, parents, and clinicians in the course of juvenile idiopathic arthritis? a qualitative study. J Rheumatol. 2014;41:2260\u20139.","journal-title":"J Rheumatol"},{"key":"161_CR4","first-page":"255","volume-title":"Insights and perspectives in rheumatology: InTech","author":"P Pelt van","year":"2012","unstructured":"van Pelt P, Wulffraat NM. Transition of care in rheumatology: managing the rheumatic patient from childhood to adulthood. In: Harrison A, editor. Insights and perspectives in rheumatology: InTech. 2012. p. 255\u201374."},{"key":"161_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1546-0096-10-37","volume":"10","author":"JA Ellis","year":"2012","unstructured":"Ellis JA, Ponsonby AL, Pezic A, Chavez RA, Allen RC, Akikusa JD, et al. CLARITY - ChiLdhood arthritis risk factor identification sTudY. Pediatr Rheumatol Online J. 2012;10:37.","journal-title":"Pediatr Rheumatol Online J"},{"key":"161_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1546-0096-10-39","volume":"10","author":"A Consolaro","year":"2012","unstructured":"Consolaro A, Ruperto N, Filocamo G, Lanni S, Bracciolini G, Garrone M, et al. Seeking insights into the EPidemiology, treatment and outcome of childhood arthritis through a multinational collaborative effort: introduction of the EPOCA study. Pediatr Rheumatol Online J. 2012;10:39.","journal-title":"Pediatr Rheumatol Online J"},{"key":"161_CR7","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1093\/rheumatology\/ket248","volume":"52","author":"F McErlane","year":"2013","unstructured":"McErlane F, Foster HE, Davies R, Lunt M, Watson KD, Symmons DP, et al. Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British society for rheumatology biologics register. Rheumatology (Oxford). 2013;52:1905\u201313.","journal-title":"Rheumatology (Oxford)"},{"key":"161_CR8","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/rheumatology\/kes019","volume":"51","author":"K Minden","year":"2012","unstructured":"Minden K, Niewerth M, Zink A, Seipelt E, Foeldvari I, Girschick H, et al. Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBO. Rheumatology (Oxford). 2012;51:1407\u201315.","journal-title":"Rheumatology (Oxford)"},{"key":"161_CR9","first-page":"45","volume":"36","author":"H Canhao","year":"2011","unstructured":"Canhao H, Faustino A, Martins F, Fonseca JE. Rheumatic diseases Portuguese register board coordination PSoR. Reuma.pt - the rheumatic diseases Portuguese register. Acta Reumatol Port. 2011;36:45\u201356.","journal-title":"Acta Reumatol Port"},{"key":"161_CR10","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1136\/ard.2007.087593","volume":"68","author":"G Horneff","year":"2009","unstructured":"Horneff G, De Bock F, Foeldvari I, Girschick HJ, Michels H, Moebius D, et al. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA registry. Ann Rheum Dis. 2009;68:519\u201325.","journal-title":"Ann Rheum Dis"},{"key":"161_CR11","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1002\/art.38741","volume":"66","author":"H Schmeling","year":"2014","unstructured":"Schmeling H, Minden K, Foeldvari I, Ganser G, Hospach T, Horneff G. Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German biologics JIA registry. Arthritis Rheumatol. 2014;66:2580\u20139.","journal-title":"Arthritis Rheumatol"},{"key":"161_CR12","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1002\/art.39197","volume":"67","author":"R Davies","year":"2015","unstructured":"Davies R, Southwood TR, Kearsley-Fleet L, Lunt M, Hyrich KL, British Society for P, et al. Medically significant infections Are increased in patients with juvenile idiopathic arthritis treated with etanercept: results from the British society for paediatric and adolescent rheumatology etanercept cohort study. Arthritis Rheumatol. 2015;67:2487\u201394.","journal-title":"Arthritis Rheumatol"},{"key":"161_CR13","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1093\/rheumatology\/kev429","volume":"55","author":"L Kearsley-Fleet","year":"2016","unstructured":"Kearsley-Fleet L, Davies R, Baildam E, Beresford MW, Foster HE, Southwood TR, et al. Factors associated with choice of biologic among children with juvenile idiopathic arthritis: results from two UK paediatric biologic registers. Rheumatology (Oxford). 2016;55:1556\u201365.","journal-title":"Rheumatology (Oxford)"},{"key":"161_CR14","unstructured":"Beukelman T, Kimura Y, Ilowite NI, Mieszkalski K, Natter MD, Burrell G, et al. The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: design, rationale, and characteristics of patients enrolled in the first 12\u00a0months. (in press)."},{"key":"161_CR15","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3899\/jrheum.100930","volume":"38","author":"G Filocamo","year":"2011","unstructured":"Filocamo G, Consolaro A, Schiappapietra B, Dalpra S, Lattanzi B, Magni-Manzoni S, et al. A new approach to clinical care of juvenile idiopathic arthritis: the juvenile arthritis multidimensional assessment report. J Rheumatol. 2011;38:938\u201353.","journal-title":"J Rheumatol"},{"key":"161_CR16","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","volume":"40","author":"EH Giannini","year":"1997","unstructured":"Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 1997;40:1202\u20139.","journal-title":"Arthritis Rheum"},{"key":"161_CR17","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/art.24516","volume":"61","author":"A Consolaro","year":"2009","unstructured":"Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum. 2009;61:658\u201366.","journal-title":"Arthritis Rheum"},{"key":"161_CR18","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2012-202031","volume":"72","author":"F McErlane","year":"2013","unstructured":"McErlane F, Beresford MW, Baildam EM, Chieng SE, Davidson JE, Foster HE, et al. Validity of a three-variable juvenile arthritis disease activity score in children with new-onset juvenile idiopathic arthritis. Ann Rheum Dis. 2013;72:1983\u20138.","journal-title":"Ann Rheum Dis"},{"key":"161_CR19","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1093\/rheumatology\/ken085","volume":"47","author":"N Adib","year":"2008","unstructured":"Adib N, Hyrich K, Thornton J, Lunt M, Davidson J, Gardner-Medwin J, et al. Association between duration of symptoms and severity of disease at first presentation to paediatric rheumatology: results from the childhood arthritis prospective study. Rheumatology (Oxford). 2008;47:991\u20135.","journal-title":"Rheumatology (Oxford)"},{"key":"161_CR20","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1093\/rheumatology\/41.12.1428","volume":"41","author":"JC Packham","year":"2002","unstructured":"Packham JC, Hall MA. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome. Rheumatology (Oxford). 2002;41:1428\u201335.","journal-title":"Rheumatology (Oxford)"},{"key":"161_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/03009740310000094","volume":"32","author":"LN Bruinooge","year":"2003","unstructured":"Bruinooge LN, El Moussaoui R, Taal E, Dijkmans BA, Van Soesbergen RM. Outcome in adults with juvenile idiopathic arthritis. Comparison of the DUTCH-AIMS2 between JIA and RA. Scand J Rheumatol. 2003;32:89\u201394.","journal-title":"Scand J Rheumatol"},{"key":"161_CR22","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/art.10863","volume":"48","author":"HE Foster","year":"2003","unstructured":"Foster HE, Marshall N, Myers A, Dunkley P, Griffiths ID. Outcome in adults with juvenile idiopathic arthritis: a quality of life study. Arthritis Rheum. 2003;48:767\u201375.","journal-title":"Arthritis Rheum"},{"key":"161_CR23","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1002\/art.1780401219","volume":"40","author":"LS Peterson","year":"1997","unstructured":"Peterson LS, Mason T, Nelson AM, O\u2019Fallon WM, Gabriel SE. Psychosocial outcomes and health status of adults who have had juvenile rheumatoid arthritis: a controlled, population-based study. Arthritis Rheum. 1997;40:2235\u201340.","journal-title":"Arthritis Rheum"},{"key":"161_CR24","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1002\/art.30426","volume":"63","author":"E Nordal","year":"2011","unstructured":"Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, et al. Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum. 2011;63:2809\u201318.","journal-title":"Arthritis Rheum"},{"key":"161_CR25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/rheumatology\/39.2.198","volume":"39","author":"M Zak","year":"2000","unstructured":"Zak M, Pedersen FK. Juvenile chronic arthritis into adulthood: a long-term follow-up study. Rheumatology (Oxford). 2000;39:198\u2013204.","journal-title":"Rheumatology (Oxford)"},{"key":"161_CR26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/1529-0131(200103)44:3<523::AID-ANR99>3.0.CO;2-1","volume":"44","author":"AR French","year":"2001","unstructured":"French AR, Mason T, Nelson AM, O\u2019Fallon WM, Gabriel SE. Increased mortality in adults with a history of juvenile rheumatoid arthritis: a population-based study. Arthritis Rheum. 2001;44:523\u20137.","journal-title":"Arthritis Rheum"},{"key":"161_CR27","first-page":"1369","volume":"33","author":"M Arkela-Kautiainen","year":"2006","unstructured":"Arkela-Kautiainen M, Haapasaari J, Kautiainen H, Leppanen L, Vilkkumaa I, Malkia E, et al. Functioning and preferences for improvement of health among patients with juvenile idiopathic arthritis in early adulthood using the WHO ICF model. J Rheumatol. 2006;33:1369\u201376.","journal-title":"J Rheumatol"},{"key":"161_CR28","first-page":"579","volume":"30","author":"F Fantini","year":"2003","unstructured":"Fantini F, Gerloni V, Gattinara M, Cimaz R, Arnoldi C, Lupi E. Remission in juvenile chronic arthritis: a cohort study of 683 consecutive cases with a mean 10\u00a0year followup. J Rheumatol. 2003;30:579\u201384.","journal-title":"J Rheumatol"},{"key":"161_CR29","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/annrheumdis-2014-206034","volume":"75","author":"AM Selvaag","year":"2016","unstructured":"Selvaag AM, Aulie HA, Lilleby V, Flato B. Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis. Ann Rheum Dis. 2016;75:190\u20135.","journal-title":"Ann Rheum Dis"},{"key":"161_CR30","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1002\/art.34458","volume":"64","author":"T Beukelman","year":"2012","unstructured":"Beukelman T, Xie F, Chen L, Baddley JW, Delzell E, Grijalva CG, et al. Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum. 2012;64:2773\u201380.","journal-title":"Arthritis Rheum"},{"key":"161_CR31","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/art.34348","volume":"64","author":"T Beukelman","year":"2012","unstructured":"Beukelman T, Haynes K, Curtis JR, Xie F, Chen L, Bemrich-Stolz CJ, et al. Rates of malignancy associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum. 2012;64:1263\u201371.","journal-title":"Arthritis Rheum"},{"key":"161_CR32","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/acr.21709","volume":"64","author":"BL Nordstrom","year":"2012","unstructured":"Nordstrom BL, Mines D, Gu Y, Mercaldi C, Aquino P, Harrison MJ. Risk of malignancy in children with juvenile idiopathic arthritis not treated with biologic agents. Arthritis Care Res (Hoboken). 2012;64:1357\u201364.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"161_CR33","unstructured":"Robinson E, Albani S, Beresford MW, de Jager W, de Roock S, Duong T, et al. Towards stratified medicine in juvenile idiopathic arthritis [abstract]. 2016 Pediatric Rheumatology European Society (PReS) Congress."},{"key":"161_CR34","doi-asserted-by":"publisher","unstructured":"Mercer LK, Askling J, Raaschou P, Dixon WG, Dreyer L, Hetland ML, et al. Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers. Ann Rheum Dis. 2017;76(2):386\u201391.","DOI":"10.1136\/annrheumdis-2016-209285"},{"key":"161_CR35","doi-asserted-by":"publisher","first-page":"e000074","DOI":"10.1136\/rmdopen-2015-000074","volume":"1","author":"C Sengler","year":"2015","unstructured":"Sengler C, Klotsche J, Niewerth M, Liedmann I, Foll D, Heiligenhaus A, et al. The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception cohort. RMD open. 2015;1:e000074.","journal-title":"RMD open"},{"key":"161_CR36","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/art.24539","volume":"61","author":"K Oen","year":"2009","unstructured":"Oen K, Tucker L, Huber AM, Miettunen P, Scuccimarri R, Campillo S, et al. Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study. Arthritis Rheum. 2009;61:1077\u201386.","journal-title":"Arthritis Rheum"},{"key":"161_CR37","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.3899\/jrheum.120110","volume":"39","author":"T Beukelman","year":"2012","unstructured":"Beukelman T, Ringold S, Davis TE, DeWitt EM, Pelajo CF, Weiss PF, et al. Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry. J Rheumatol. 2012;39:1867\u201374.","journal-title":"J Rheumatol"},{"key":"161_CR38","first-page":"622","volume":"29","author":"K Minden","year":"2002","unstructured":"Minden K, Niewerth M, Listing J, Zink A. German study group of pediatric R. Health care provision in pediatric rheumatology in Germany--national rheumatologic database. J Rheumatol. 2002;29:622\u20138.","journal-title":"J Rheumatol"},{"key":"161_CR39","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/ard.2007.087411","volume":"68","author":"FH Prince","year":"2009","unstructured":"Prince FH, Twilt M, ten Cate R, van Rossum MA, Armbrust W, Hoppenreijs EP, et al. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register. Ann Rheum Dis. 2009;68:635\u201341.","journal-title":"Ann Rheum Dis"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-017-0161-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T00:16:42Z","timestamp":1492561002000},"score":1,"resource":{"primary":{"URL":"http:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-017-0161-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,19]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["161"],"URL":"https:\/\/doi.org\/10.1186\/s12969-017-0161-5","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,19]]},"article-number":"31"}}